Drug intelligence / Profile preview

yinxieling

Development stage
Unknown
Lead developer
Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Yinxieling is a Traditional Chinese Medicine (TCM) herbal formula developed and utilized by the Guangdong Provincial Hospital of Traditional Chinese Medicine for the treatment of psoriasis vulgaris. It is primarily indicated for patients exhibiting the blood-stasis or blood-heat syndromes according to TCM diagnostic criteria. The formula is composed of multiple herbal ingredients, including *Rehmannia glutinosa*, *Salvia miltiorrhiza*, and *Dictamnus dasycarpus*, which are thought to work synergistically to modulate the immune system, inhibit keratinocyte proliferation, and reduce systemic inflammation. Clinical research has focused on its ability to alter microRNA expression profiles and downregulate pro-inflammatory cytokines such as TNF-α, IL-17, and IL-23, which are central to the pathogenesis of psoriasis.

Brand names
Yinxieling tablets
Other names
Yinxieling GranulesYinxieling DecoctionYinxieling FormulaYXL
02

Targets

FUS (Fused in sarcoma)IL-23 (Interleukin-23)IL8 (C-X-C Motif Chemokine Ligand 8)PCNA (Proliferating cell nuclear antigen)TGFB1 (Transforming growth factor Beta-1 proprotein)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on yinxieling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yinxieling.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call